Abstract
Parkinson's disease (PD) is the second most prevalent progressive neurodegenerative disease in the world, affecting approximately 10 million people globally. With no known cure, the management of PD still faces substantial challenges in both diagnosis and treatment. The disease is characterized by the death of dopaminergic neurons in the midbrain, resulting in significant motor and cognit…